Question 1

What is Evolocumab?

Accepted Answer

Evolocumab is a monoclonal antibody that functions as a PCSK9 inhibitor. It targets and binds to a specific protein in the body called proprotein convertase subtilisin/kexin type 9.

This protein normally limits the number of receptors on the liver that are responsible for removing cholesterol from the blood. By blocking this protein, the medication allows the liver to clear more low-density lipoprotein (LDL) cholesterol, which is commonly known as bad cholesterol.

Question 2

What is Evolocumab used for?

Accepted Answer

Evolocumab is used to treat:

Primary hyperlipidemia

Homozygous familial hypercholesterolemia

Cardiovascular risk reduction

Question 3

How does Evolocumab work?

Accepted Answer

The Role of LDL Receptors

The liver plays a key role in managing cholesterol levels. It uses specialized proteins on its surface called LDL receptors to capture "bad" cholesterol from the blood and bring it into the liver cells to be broken down and removed from the body.

How PCSK9 Affects Cholesterol

The body naturally produces a protein called proprotein convertase subtilisin/kexin type 9 (PCSK9). This protein binds to the LDL receptors on the liver and causes them to be destroyed. When there are fewer receptors available on the liver's surface, less cholesterol is removed from the blood, leading to higher levels of LDL cholesterol.

How Evolocumab Works

Evolocumab is a PCSK9 inhibitor. It works by attaching to the PCSK9 protein and preventing it from binding to the LDL receptors. This process leads to several effects:

Increased Receptors: More LDL receptors remain active on the surface of the liver cells.

Improved Clearance: The liver can more efficiently pull "bad" cholesterol out of the bloodstream.

Lower Cholesterol Levels: As more cholesterol is removed and processed by the liver, the amount of LDL cholesterol circulating in the blood decreases significantly.

Because it works through this specific protein pathway, it is often used in combination with other cholesterol-lowering treatments, such as statins, to further reduce the risk of cardiovascular events.

Question 4

What are the brand names for Evolocumab?

Accepted Answer

Evolocumab is sold under the brand name Repatha .

Question 5

What are the active ingredients in Evolocumab?

Accepted Answer

The active ingredient in Evolocumab is evolocumab .

Question 6

What are the side effects of Evolocumab?

Accepted Answer

Common side effects of Evolocumab may include:

nasopharyngitis

back pain

injection site reactions

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Evolocumab?

Accepted Answer

Evolocumab belongs to the PCSK9 inhibitor drug class.

Question 8

What is the dosage of Evolocumab and how do I take it?

Accepted Answer

Administration

Evolocumab is given as a subcutaneous injection. It is commonly injected into the front of the thigh, the abdomen, or the outer area of the upper arm. It is important to rotate the injection site with each dose to avoid skin irritation.

Before administration, the medication should be removed from the refrigerator and allowed to reach room temperature naturally. Do not shake the medication or use heat sources, such as a microwave or hot water, to warm it up. Check the liquid to ensure it is clear and colorless to slightly yellow; do not use it if it is cloudy, discolored, or contains large particles.

Dosing Frequency

The medication is usually scheduled for administration either once every two weeks or once a month, depending on the condition being treated and the specific product used. Your healthcare provider will determine the appropriate schedule for your needs.

Missed Dose

If a dose is missed, it should be administered as soon as possible if it is within the timeframe recommended by your healthcare provider. If too much time has passed since the missed dose, skip it and wait until the next scheduled dose. Do not use extra medicine to make up for a missed dose.

Question 9

Is Evolocumab safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There are no adequate and well-controlled studies of evolocumab use in pregnant women. As a monoclonal antibody, evolocumab is expected to be transported across the placenta as a pregnancy progresses, particularly during the second and third trimesters. This means the medication has the potential to be transmitted from the mother to the developing fetus.

In animal studies, no adverse effects on pregnancy or neonatal development were observed. However, because animal reproduction studies are not always predictive of human response, the use of this medication during pregnancy is generally only considered when the potential benefit justifies the potential risk to the fetus.

Breastfeeding

It is not known whether evolocumab is excreted in human milk. While many medications can pass into breast milk, it is currently unknown if evolocumab does so or if it could affect a nursing infant. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the medication to the mother.

Individuals who are pregnant, planning to become pregnant, or breastfeeding should discuss their treatment options and potential risks with their healthcare provider.

Question 10

What forms and strengths does Evolocumab come in?

Accepted Answer

Available Forms

Evolocumab is a liquid solution administered by subcutaneous injection. It is available in the following single-use delivery systems:

Prefilled Syringe: A manual injection device for single-use administration.

Prefilled Autoinjector: A device that automates the injection process.

On-body Infusor with Prefilled Cartridge: A wearable system that delivers the medication from a cartridge over a short period.

Each delivery format is intended for one-time use only and does not contain preservatives.

Question 11

What is the FDA approval status of Evolocumab?

Accepted Answer

FDA Approval History

The U.S. Food and Drug Administration (FDA) first approved evolocumab in August 2015. It was the second medication in the PCSK9 inhibitor class to reach the market. Since its initial approval, the FDA has expanded its indications to include broader cardiovascular risk reduction and use in pediatric populations.

Approved Indications

Evolocumab is currently FDA-approved for the following uses:

Cardiovascular Risk Reduction: To reduce the risk of heart attack, stroke, and coronary revascularization in adults with established cardiovascular disease.

Primary Hyperlipidemia: To lower low-density lipoprotein cholesterol (LDL-C) in adults with primary hyperlipidemia, including heterozygous familial hypercholesterolemia (HeFH).

Homozygous Familial Hypercholesterolemia (HoFH): To lower LDL-C in adults and pediatric patients aged 10 years and older with this rare genetic condition.

Safety and Regulatory Status

There are currently no Boxed Warnings or Risk Evaluation and Mitigation Strategy (REMS) programs required by the FDA for evolocumab. The medication is available only by prescription and is intended for use in combination with a heart-healthy diet, either alone or alongside other cholesterol-lowering therapies like statins.

Regulatory approval was supported by clinical trials demonstrating that evolocumab significantly lowers LDL cholesterol levels and reduces the occurrence of major cardiovascular events in patients with high risk or established heart disease.

Question 12

What should I know about Evolocumab and cost?

Accepted Answer

Insurance and Prior Authorization

Evolocumab is a specialty medication that often requires prior authorization from insurance providers. This process involves your healthcare provider submitting documentation to prove the medical necessity of the drug before the insurance company agrees to cover the cost.

Out-of-Pocket Expenses

The amount you pay out-of-pocket depends on your specific insurance plan's formulary, deductible, and copayment or coinsurance requirements. For those without insurance, the retail price of the medication is generally high, reflecting its status as a biologic therapy.

Financial Support Options

There are several resources that may help manage the cost of evolocumab:

Manufacturer Copay Cards: These are often available for patients with commercial or private insurance to help reduce monthly copayments.

Patient Assistance Programs: These programs are designed for patients who lack insurance coverage or meet specific low-income criteria, potentially providing the medication at no cost.

Foundation Support: Independent charitable foundations may offer grants to help cover the cost of cholesterol-lowering medications for patients with specific medical conditions.

Patients are encouraged to speak with their pharmacist or insurance representative to get the most accurate estimate of their costs.

Evolocumab

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Brand Names

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Price Information

FAQ

Additional Resources

Support & Help Resources

Found an Error?